GB9819020D0 - Chemical compounds III - Google Patents

Chemical compounds III

Info

Publication number
GB9819020D0
GB9819020D0 GBGB9819020.0A GB9819020A GB9819020D0 GB 9819020 D0 GB9819020 D0 GB 9819020D0 GB 9819020 A GB9819020 A GB 9819020A GB 9819020 D0 GB9819020 D0 GB 9819020D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds iii
iii
chemical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9819020.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis Research Ltd
Original Assignee
Cerebrus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerebrus Ltd filed Critical Cerebrus Ltd
Priority to GBGB9819020.0A priority Critical patent/GB9819020D0/en
Publication of GB9819020D0 publication Critical patent/GB9819020D0/en
Priority to AU56374/99A priority patent/AU5637499A/en
Priority to PCT/GB1999/002883 priority patent/WO2000012482A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9819020.0A 1998-09-01 1998-09-01 Chemical compounds III Ceased GB9819020D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9819020.0A GB9819020D0 (en) 1998-09-01 1998-09-01 Chemical compounds III
AU56374/99A AU5637499A (en) 1998-09-01 1999-09-01 Chemical compounds iii
PCT/GB1999/002883 WO2000012482A2 (fr) 1998-09-01 1999-09-01 Composes chimiques iii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9819020.0A GB9819020D0 (en) 1998-09-01 1998-09-01 Chemical compounds III

Publications (1)

Publication Number Publication Date
GB9819020D0 true GB9819020D0 (en) 1998-10-28

Family

ID=10838155

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9819020.0A Ceased GB9819020D0 (en) 1998-09-01 1998-09-01 Chemical compounds III

Country Status (3)

Country Link
AU (1) AU5637499A (fr)
GB (1) GB9819020D0 (fr)
WO (1) WO2000012482A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
PL365422A1 (en) * 2000-03-17 2005-01-10 Alcon, Inc. 5-hydroxy indazole derivatives for treating glaucoma
US7005443B1 (en) 2000-03-17 2006-02-28 Alcon, Inc. 5-Hydroxy indazole derivatives for treating glaucoma
CA2449899C (fr) 2000-11-20 2010-04-06 Biovitrum Ab Composes de piperazinylpyrazines utilises comme antagonistes du recepteur de la serotonine 5-ht2
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
CA2432122A1 (fr) 2000-12-20 2002-08-01 Bristol-Myers Squibb Pharma Company Ligands d'agoniste et d'antagoniste du recepteur de serotonine a substitution aryle et aminoaryle
CN100484933C (zh) 2002-06-19 2009-05-06 比奥维特罗姆股份公开公司 新的吡嗪化合物及其在制备用于治疗与5-羟色胺相关的疾病的药物中的用途
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
GB0314967D0 (en) 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
EP2248524A3 (fr) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Agents preventifs/remedes pour l'incontinence de stress et procede de selecetion de ceux-ci
AU2005300045A1 (en) 2004-09-27 2006-05-04 Organix, Inc. Indole compounds useful as serotonin selective agents
WO2006103511A1 (fr) 2005-03-31 2006-10-05 Pfizer Products Inc. Derives de cyclopentapyridine et de tetrahydroquinoline
EP2742936A1 (fr) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Composé hétérocyclique condensé et son utilisation
EP2789338A3 (fr) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Dérivé de pyridine condensé et son utilisation
KR101062376B1 (ko) 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
WO2015066344A1 (fr) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. Agonistes du récepteur 5-ht2c et compositions et procédés d'utilisation
EP3733204A4 (fr) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited Agent thérapeutique pour incontinence urinaire de stress et incontinence fécale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494774A1 (fr) * 1991-01-11 1992-07-15 MERCK SHARP & DOHME LTD. Composés hétéroaromatiques à 5 chaînons substitués par l'indazole
JPH08165276A (ja) * 1994-12-14 1996-06-25 Dainippon Pharmaceut Co Ltd ２−アルキルアミノ−１−フェニルエタノール誘導体
AU5343298A (en) * 1997-01-13 1998-08-03 Yamanouchi Pharmaceutical Co., Ltd. 5-ht2c receptor agonists and aminoalkylindazole derivatives

Also Published As

Publication number Publication date
WO2000012482A3 (fr) 2000-05-25
WO2000012482A2 (fr) 2000-03-09
AU5637499A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
GB9800428D0 (en) Chemical compounds
GB9813565D0 (en) Chemical compounds
GB9811159D0 (en) Chemical compounds
GB9812709D0 (en) Chemical compounds
GB9813554D0 (en) Chemical compounds
GB9812088D0 (en) Chemical compounds
GB9804343D0 (en) Chemical compounds
GB9819020D0 (en) Chemical compounds III
GB9928414D0 (en) Chemical compounds III
GB9804861D0 (en) Chemical compounds
GB9815785D0 (en) Chemical compounds
GB9801812D0 (en) Chemical compounds
GB9802028D0 (en) Chemical compounds
GB9809161D0 (en) Chemical compounds
GB9801499D0 (en) Chemical compounds iii
GB9801963D0 (en) Chemical compounds
GB9811417D0 (en) Chemical compounds
GB9804161D0 (en) Chemical compounds
GB9803169D0 (en) Chemical compounds
GB9803029D0 (en) Chemical compounds
GB9802762D0 (en) Chemical compounds
GB9802066D0 (en) Chemical compounds
GB9805497D0 (en) Chemical compounds
GB9805498D0 (en) Chemical compounds
GB9806309D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)